Drug Information

Drug General Information
Drug ID
D0B4ZQ
Former ID
DIB001411
Drug Name
SL-90.0571
Indication Epilepsy [ICD10:G40] Discontinued in Phase 1 [545133]
Company
Synthelabo
Canonical SMILES
c12c(C3COC(OC3)CCCNC(=O)C)cccc1cc(cc2)OC
CAS Number
CAS 139293-31-5
Target and Pathway
Target(s) Sodium channel Target Info Modulator [550935]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and Ankyrins
References
Ref 545133Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002249)
Ref 550935WO patent application no. 19990639849, Novel sodium channel drugs and uses.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.